Surgical Drainage Devices Market Current and Future Projection 2022-2032

Posted by Ganesh Shinde on December 13th, 2022

Global Surgical Drainage Devices Market was valued at US$ 1.3 Bn in 2021 and is expected to reach US$ 2.9 Bn by 2032, finds Future Market Insights (FMI) in a recent market survey. The growth of the market for Active Drains is projected to expand at a CAGR of around 7.8% during 2022 – 2032. The value of Active Drains Market increased at a CAGR of around 6.7% during 2017 – 2021.  

Active drains are systems that collect fluid and deposit it in reservoirs. These reservoirs reduce hospital workers' exposure to contaminated fluid. Active drains use an artificial pressure gradient to remove fluid from a wound or body cavity.

According to the National Library of Medicine, patients with active drains experienced 6% delayed healing compared to 54% for those with passive drains.

Active drains play an important role in improving the outcome of cardiothoracic surgeries, especially in children. As a result, the use of active surgical drain devices among a wide range of end-users has increased along with an increase in the prevalence of chronic diseases like arthritis and osteoporosis. This appears to be primarily driven by significant progress in the medical device industry.

Impact of Covid-19 on the Surgical Drainage Devices Market

The pandemic disrupted routine hospital services all over the world. For patient safety, the hospital reduces the number of elective surgeries during the pandemic. Reduced elective surgery protected patients from viral transmission, but it reduced global demand for Surgical Drainage Devices. According to a British journal of surgery report, over 20 million elective surgeries were canceled during the pandemic.

Competitive Landscape

Some of the key players in Surgical Drainage Devices include Acelity, Teleflex Incorporated, Cardinal Health, Medtronic, Cook Medical, Johnson and Johnson, B. Braun Melsungen AG, Smith & Nephew plc, Stryker, Becton Dickinson, and Centese.

Some of the recent developments of key surgical drains devices providers are as follows:

• In October 2021, Centese created a self-cleaning chest tube device that offers more accurate measurements for keeping tabs on patients recuperating from heart or lung surgery. The device developed by Centese is called the Thoraguard device. This device will help Centese accelerate its growth in the segment of surgical drainage devices.
• In April 2019, Smith & Nephew plc announced the acquisition of Osiris Therapeutics, Inc. This addition will further accelerate the growth of Smith & Nephew’s surgical drains business and advance the wound care franchise.
• In October 2019, 3M announced the acquisition of Acelity, Inc.

Browse More@ https://www.futuremarketinsights.com/reports/surgical-drainage-devices-market